Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
Carla Colombo, Gianfranco Alicandro, Valeria Daccò, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251527-e0251527
Open Access | Times Cited: 22

Showing 22 citing articles:

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation
Valentino Bezzerri, Valentina Gentili, Martina Api, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells
Virginia Lotti, Flavia Merigo, Anna Lagni, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 18
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
Carla Colombo, Marco Cipolli, Valeria Daccò, et al.
Infection (2021) Vol. 50, Iss. 3, pp. 671-679
Open Access | Times Cited: 24
Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
Vito Terlizzi, Marco Antonio Motisi, Roberta Pellegrino, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 16
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation
Francesca Lucca, Valentino Bezzerri, Elisa Danese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 908-908
Open Access | Times Cited: 9
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis
Anke Jaudszus, Mariya Pavlova, Marius Rasche, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
Antonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV‐2 infection and COVID‐19 disease severity
Philip R. Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
Carmelo Biondo, Angelina Midiri, Elisabetta Gerace, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2087-2087
Open Access | Times Cited: 6
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2
Davide Ferrari, Michele Rubini, Jorge S. Burns
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Respiratory Viruses and Cystic Fibrosis
Kate Brackenborough, Huw Ellis, W.G. Flight
Seminars in Respiratory and Critical Care Medicine (2022) Vol. 44, Iss. 02, pp. 196-208
Closed Access | Times Cited: 5
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
Gianfranco Alicandro, Valeria Daccò, Lisa Cariani, et al.
Journal of Cystic Fibrosis (2021) Vol. 21, Iss. 2, pp. e113-e116
Open Access | Times Cited: 5
A COVID–19-fertőzéssel és -immunizációval szerzett tapasztalatok felnőtt cystás fibrosisos betegcsoportban
Zoltán Örlős, Zsuzsanna Miklós, Ildikó Horváth
Orvosi Hetilap (2024) Vol. 165, Iss. 9, pp. 332-337
Open Access
Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis
Kathleen Mahan, S. Kiel, Rebecca Freese, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27567-e27567
Open Access
Occurrence of COVID-19 in cystic fibrosis patients: a review
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
ACE2 expression and localization are regulated by CFTR: implications beyond cystic fibrosis
Valentino Bezzerri, Valentina Gentili, Martina Api, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Incidence, prevalence, clinical features, and outcomes of COVID-19 in persons with cystic fibrosis: a systematic review protocol
Sherly Antony, Saritha Susan Vargese, Mercy John Idikula, et al.
JBI Evidence Synthesis (2022)
Open Access | Times Cited: 1
Clinical characteristics and outcomes of incident cases of COVID-19 in unvaccinated adult cystic fibrosis patients in southern Brazil: a prospective cohort study conducted during the first year of the COVID-19 pandemic
Cristiane Christ Camargo, Letícia Bauer Jacobsen, Jaqueline Wilsmann, et al.
Jornal Brasileiro de Pneumologia (2022), pp. e20220265-e20220265
Open Access | Times Cited: 1
La pagina gialla
Alessandro Ventura
Medico e Bambino (2020) Vol. 39, Iss. 7, pp. 417-418
Closed Access
La pagina gialla
Alessandro Ventura
Medico e Bambino (2021) Vol. 40, Iss. 6, pp. 351-352
Closed Access
Page 1

Scroll to top